- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04145245
A Randomized Controlled Trial to Assess the Effect of L-carnitine in Patients With Diabetic Peripheral Neuropathy to Relief Pain and Symptom Improvement
Study Overview
Detailed Description
Study Type
Enrollment (Anticipated)
Phase
- Phase 2
Contacts and Locations
Study Contact
- Name: Farhana Haque, MBBS
- Phone Number: 01734342464
- Email: farhanahaque857@gmail.com
Study Contact Backup
- Name: Zesmin Dewan, PHD
- Phone Number: 01712533169
- Email: jfdewan@gmail.com
Study Locations
-
-
Dhaka,Sahbagh
-
Dhaka, Dhaka,Sahbagh, Bangladesh, 02
- Recruiting
- Pharmacology department,BSMMU.
-
Contact:
- Farhana Haque, MBBS
- Phone Number: 01734342464
- Email: farhanahaque857@gmail.com
-
Contact:
- Zesmin Dewan, PHD
- Phone Number: 01712533169
- Email: jfdewan@gmail.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
i. Clinically diagnosed diabetic patients who had been on stable antidiabetic therapy for 1 year ii.Age: 18 years to 70 years iii. Patients HbA1c level <10
Exclusion Criteria:
i. Patient who are suffering from other causes of peripheral neuropathy for example chemotherapy and HIV patient, rheumatoid arthritis, SLE, alcololism, vitamin B12 deficiency etc ii. Lactating and pregnant women iii. Patients taking anticonvulsants, antidepressants, opoioids and other neuropathic pain medication agents
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Intervention or group a
Diabetic neuropathy patients with antidiabetic therapy in addition with l-carnitine supplementation
|
Levocarnitine syrup- oral supplementation about 1500 mg/day for 10 weeks
Other Names:
|
PLACEBO_COMPARATOR: Placebo or group b
Diabetic neuropathy patients with antidiabetic treatment in addition with placebo
|
Levocarnitine syrup- oral supplementation about 1500 mg/day for 10 weeks
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
VAS score
Time Frame: 10 weeks
|
Alleviation of VAS Score of pain
|
10 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Improvement of neuropathic symptom
Time Frame: 10 weeks
|
Alleviation of NSS and NDS of diabetic neuropathy
|
10 weeks
|
Collaborators and Investigators
Investigators
- Principal Investigator: Farhana Haque, MBBS, Resident, phase-B
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- BSMMU/2019/3936
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Patient Compliance
-
HaEmek Medical Center, IsraelUnknownPatient Satisfaction | Patient Compliance
-
University of AarhusUnknownPatient Engagement | Patient Empowerment | Patient Compliance
-
Xijing Hospital of Digestive DiseasesRecruiting
-
Shara Qadir HusseinCompleted
-
University of CalgaryCompleted
-
Mansoura UniversityCompleted
-
E-DA HospitalUnknownCompliance, Patient
-
Tata Memorial HospitalCompleted
-
Massachusetts General HospitalCompleted
-
Arizona State UniversityJ.B. Sutton Elementary SchoolCompletedPatient ComplianceUnited States
Clinical Trials on Levocarnitine
-
Bangabandhu Sheikh Mujib Medical University, Dhaka...UnknownPatient ComplianceBangladesh
-
Lee's Pharmaceutical LimitedCompleted
-
Vanderbilt University Medical CenterRecruitingKeratoconjunctivitis Sicca | Sjogren's SyndromeUnited States
-
The First Affiliated Hospital of Zhejiang Chinese...Not yet recruiting
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)CompletedFatigue | Unspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Montefiore Medical CenterThe Gerber FoundationCompletedPrematurity | Neurodevelopmental Disorder | Carnitine DeficiencyUnited States
-
Karen Lindhardt MadsenRigshospitalet, DenmarkCompletedCarnitine Transporter, Plasma-membrane, Deficiency of
-
Children's Hospital of Orange CountyUniversity of California, IrvineRecruitingAcute Lymphoblastic Leukemia | HepatotoxicityUnited States
-
Maastricht University Medical CenterCompleted
-
Dr. Amer JohriQueen's University; Heart and Stroke Foundation of CanadaCompleted